companydata.dkcompanydata.dk

Eurofins Genomics Denmark A/S: Financial statements 2017

CVR: 10048818

Source: annual report 2017, Danish Business Authority

01/01/2017 – 31/12/2017

Eurofins Genomics Denmark A/S (CVR 10048818) has filed annual accounts for 2017. In 2017, the company reported a gross profit of DKK 14,526,644 and a net result of DKK 963,492 compared with DKK -3,936,856 the year before. That is an increase of 20.8% compared with the year before. Equity in the 2017 report amounted to DKK 11,792,463. The solvency ratio was 26.8%.

Gross Profit
DKK 14,526,644
Profit/Loss
DKK 963,492
Equity
DKK 11,792,463
Total Assets
DKK 44,062,908

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2017-14.5M963K11.8M-
2016-12M-3.9M10.8M-
2015-19.9M-1.6M16.8M26
2014-27M4.8M20.4M-
2013-22.2M2.2M17.1M-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Keep an eye on Eurofins Genomics Denmark A/S

Get notified instantly about new financial statements, ownership changes, management changes and status changes.

Set up monitoring

Events in 2017

Eurofins Genomics Denmark A/S: The 2016 annual report is outJun 13, 2017

Eurofins Genomics Denmark A/S has published its annual report for 2016. Gross profit came to DKK 12,026,280, and the net result was DKK -3,936,856.

Daniel Schougaard Langhoff joins Eurofins Genomics Denmark A/S as adm. dir.Jan 1, 2017

As of January 1, 2017, Daniel Schougaard Langhoff is registered as adm. dir. of Eurofins Genomics Denmark A/S.

About Eurofins Genomics Denmark A/S

Eurofins Genomics Denmark A/S is a Danish company of the type Aktieselskab based in Galten, founded in 2000. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named Eurofins Genomics Europe AgriGenomics Products & Services A/S and Eurofins Genomics Europe Genotyping A/S. The management consists of Jacob Sickmann Ransborg. The board consists of Svend Aage Linde (chair), Jacob Sickmann Ransborg and Ulrich August Werner Kühle. The company is owned by Eurofins Genomics LUX Holding SARL. The company has 68 employees (2026). In 2025, the company reported a gross profit of DKK 43,634,455 and a net result of DKK -8,643,885 compared with DKK -12,812,295 the year before. Equity in the 2025 report amounted to DKK 14,211,619.

Source: annual report 2025, Danish Business Authority